QUINIDINE GLUCONATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for quinidine gluconate and what is the scope of freedom to operate?
Quinidine gluconate
is the generic ingredient in six branded drugs marketed by Lilly, Warner Chilcott, Bayer Hlthcare, Chartwell Molecular, Watson Labs, Ani Pharms, Ascot, Cycle, Halsey, Hibrow Hlthcare, Rising, Sun Pharm Industries, and Superpharm, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.There are nine drug master file entries for quinidine gluconate. Four suppliers are listed for this compound.
Summary for QUINIDINE GLUCONATE
US Patents: | 0 |
Tradenames: | 6 |
Applicants: | 13 |
NDAs: | 16 |
Drug Master File Entries: | 9 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 40 |
Patent Applications: | 2,169 |
Drug Prices: | Drug price trends for QUINIDINE GLUCONATE |
What excipients (inactive ingredients) are in QUINIDINE GLUCONATE? | QUINIDINE GLUCONATE excipients list |
DailyMed Link: | QUINIDINE GLUCONATE at DailyMed |
Pharmacology for QUINIDINE GLUCONATE
Drug Class | Antiarrhythmic Cytochrome P450 2D6 Inhibitor |
Mechanism of Action | Cytochrome P450 2D6 Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for QUINIDINE GLUCONATE
US Patents and Regulatory Information for QUINIDINE GLUCONATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hibrow Hlthcare | QUINIDINE GLUCONATE | quinidine gluconate | TABLET, EXTENDED RELEASE;ORAL | 212589-001 | Sep 17, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Halsey | QUINIDINE GLUCONATE | quinidine gluconate | TABLET, EXTENDED RELEASE;ORAL | 089476-001 | Apr 10, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ani Pharms | QUINIDINE GLUCONATE | quinidine gluconate | TABLET, EXTENDED RELEASE;ORAL | 087810-001 | Sep 29, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cycle | QUINIDINE GLUCONATE | quinidine gluconate | TABLET, EXTENDED RELEASE;ORAL | 088431-001 | Jan 6, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Warner Chilcott | DURAQUIN | quinidine gluconate | TABLET, EXTENDED RELEASE;ORAL | 017917-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.